Monopar Therapeutics (MNPR) Interest & Investment Income (2022 - 2025)
Monopar Therapeutics (MNPR) reported Interest & Investment Income of -$65763.0 for Q3 2025, down 166.2% on a YoY basis from $99344.0 in Q3 2024, and down 108.42% sequentially from $780769.0 in Q2 2025.
Monopar Therapeutics (MNPR) Interest & Investment Income (2022 - 2025) Analysis & Trends
Monopar Therapeutics (MNPR) has 4 years of Interest & Investment Income data on file, last reported at -$65763.0 in Q3 2025.
- For the quarter ending Q3 2025, Interest & Investment Income fell 166.2% year-over-year to -$65763.0; the trailing twelve-month figure through Sep 2025 stood at $814696.0 (up 249.29% YoY), and the FY2023 full-year result was $800998.0, up 27.12% from the prior year.
- Interest & Investment Income slipped to -$65763.0 in Q3 2025, from $780769.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $800998.0 in Q4 2023 to a low of -$65763.0 in Q3 2025.
- A 4-year average of $217561.3 and a median of $33645.0 in 2023 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 31846.36% in 2025, while the deepest fall reached 166.2% in 2025.
- Tracing MNPR's Interest & Investment Income over 4 years: stood at $630113.0 in 2022, then rose by 27.12% to $800998.0 in 2023, then sank by 87.6% to $99344.0 in 2024, then plunged by 166.2% to -$65763.0 in 2025.
- Business Quant data shows MNPR's Interest & Investment Income at -$65763.0 in Q3 2025, $780769.0 in Q2 2025, and $346.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Monopar Therapeutics | 800.03 Mn | 738.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -65,763.00 |
| Jun 30, 2025 | 780,769.00 |
| Mar 31, 2025 | 346.00 |
| Sep 30, 2024 | 99,344.00 |
| Jun 30, 2024 | 2,444.00 |
| Mar 31, 2024 | 19,198.00 |
| Dec 31, 2023 | 800,998.00 |
| Sep 30, 2023 | 112,260.00 |
| Jun 30, 2023 | -20,180.00 |
| Mar 31, 2023 | 33,645.00 |
| Dec 31, 2022 | 630,113.00 |